Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2001-06-15
2004-11-09
McGarry, Sean (Department: 1635)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S006120, C435S320100, C435S325000, C435S243000, C435S252100, C435S252300, C435S252330, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
06815180
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a novel protooncogene and protein encoded therein, and more particularly, to a human cervical cancer 1 protooncogene and a protein derived therefrom, which can be used in diagnosis of various cancers.
BACKGROUND OF THE INVENTION
Higher animals including man each carry approximately 100,000 genes, but only about 15% thereof is expressed, and characteristics of individual's biological process, e.g., genesis, differentiation, homeostasis, responses to stimuli, control of cell segmentation, aging and apoptosis(programmed cell death), are determined depending on which genes are expressed(see Liang, P. and A. B. Pardee,
Science
, 257: 967-25 971(1992)).
Pathogenic phenomena such as tumorigenesis are caused by gene mutation which brings about changes in the mode of gene expression. Therefore, comparative studies of gene expressions in various cells have been conducted to provide bases for establishing viable approaches to the understanding of diverse biological phenomena.
For example, the MRNA differential display(DD) method suggested by Liang and Pardee is effective in elucidating the nature of tumor suppressor genes, cell cycle-related genes and transcriptional regulatory genes that control apoptosis(see Liang, P. and A. B. Pardee supra). Further, the DD method has been widely used in examining the interrelationship of various genes in a cell.
It has been reported that tumorigenesis is caused by various genetic changes such as the loss of chromosomal heterozygosity, activation of oncogenes and inactivation of tumor suppressor genes, e.g., p53 gene(see Bishop, J. M.,
Cell
, 64: 235-248(1991); and Hunter, T.,
Cell
, 64: 249-270(1991)). Further, it has been reported that 10 to 30% of human cancer arises from the activation of oncogene through amplification of protooncogenes.
Therefore, the activation of protooncogenes plays an important role in the etiology of many tumors and there has existed a need to identify protooncogenes.
The present inventor has endeavored to unravel examine the mechanism involved in the tumorigenesis of cervical cancer; and, has unexpectedly found that a novel protooncogene, human cervical cancer 1(HCCR-1), is specifically overexpressed in cancer cells. This protooncogene can be effectively used in diagnosis, prevention and treatment of various cancers, e.g., leukemia, lymphoma, kidney, liver, lung, ovary and uterine cervix cancers.
SUMMARY OF THE INVENTION
Accordingly, the primary object of the present invention is to provide a novel protoncogene and a fragment thereof.
Other objects of the present invention are to provide:
a recombinant vector containing said protooncogene or a fragment thereof and a microorganism transformed therewith;
a protein encoded in said protooncogene and a fragment thereof;
a kit for diagnosis of cancer containing said protooncogene or a fragment thereof;
a kit for diagnosis of cancer containing said protein or a fragment thereof;
an anti-sense gene having a base sequence complementary to that of said protooncogene or a fragment thereof; and
a process for treating or preventing cancer by using said anti-sense gene.
In accordance with one aspect of the present invention, there is provided a novel protooncogene having the nucleotide sequence of SEQ ID No:1 or a fragment thereof.
In accordance with another aspect of the present invention, there is provided a recombinant vector containing said protooncogene or a fragment thereof and a microorganism transformed with said vector.
In accordance with still another aspect of the present invention, there is provided a protein having the amino acid sequence of SEQ ID No:2 or a fragment thereof derived from said protooncogene or a fragment thereof
REFERENCES:
New England Biolabs Catalog, pp. 106-108, 1995.*
Jen et al., Stem Cell, vol. 18:307-319, 2000.*
Branch A., TIBS, vol. 23:45-.*
Agrawal, S., TIBTECH, vol. 14:376-387, 1996.
Anderson Kill & Olick PC
McGarry Sean
LandOfFree
Human cervical cancer 1 protooncogene and protein encoded... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human cervical cancer 1 protooncogene and protein encoded..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human cervical cancer 1 protooncogene and protein encoded... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3351577